0001179110-15-008909.txt : 20150602 0001179110-15-008909.hdr.sgml : 20150602 20150602170730 ACCESSION NUMBER: 0001179110-15-008909 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150529 FILED AS OF DATE: 20150602 DATE AS OF CHANGE: 20150602 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALERE INC. CENTRAL INDEX KEY: 0001145460 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 043565120 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 51 SAWYER ROAD STREET 2: SUITE 200 CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 7816473900 MAIL ADDRESS: STREET 1: 51 SAWYER ROAD STREET 2: SUITE 200 CITY: WALTHAM STATE: MA ZIP: 02453 FORMER COMPANY: FORMER CONFORMED NAME: INVERNESS MEDICAL INNOVATIONS INC DATE OF NAME CHANGE: 20010720 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BRIDGEN JOHN CENTRAL INDEX KEY: 0001272539 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-16789 FILM NUMBER: 15907715 MAIL ADDRESS: STREET 1: 51 SAWYER ROAD STREET 2: C/O INVERNESS MEDICAL INNOVATIONS INC CITY: WALTHAM STATE: MA ZIP: 02453 4 1 edgar.xml FORM 4 - X0306 4 2015-05-29 0 0001145460 ALERE INC. ALR 0001272539 BRIDGEN JOHN 51 SAWYER ROAD, SUITE 200 WALTHAM MA 02453 0 1 0 0 Sr VP, Business Develop Common Stock 2015-05-29 4 M 0 22564 35.58 A 27116 D Common Stock 2015-05-29 4 S 0 22564 51.165 D 4552 D Employee Stock Option (Right to Buy) 35.58 2015-05-29 4 M 0 22564 D 2019-06-30 Common Stock 22564 0 D Represents same day exercise and sale of stock options. Option vested in four equal annual installments on 6/30/10, 6/30/11, 6/30/12 and 6/30/13. This derivative security does not have a price. The price reported is a weighted average price. These shares were sold in approximately 122 separate transactions at prices ranging from $51.00 to $51.385, inclusive. The reporting person hereby undertakes to provide to the SEC, the issuer or any stockholder of the issuer, upon request, the full information regarding the number of shares and prices at which the transaction was affected. /s/ Jay McNamara, Attorney-in-Fact 2015-06-02